Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group

Journal of Clinical Oncology

Volumn 15, Issue 1, 1997, Pages 76-84

  Provisor, A J ^a   Ettinger, L J ^a   Nachman, J B ^a   Krailo, M D ^a   Makley, J T ^a   Yunis, E J ^a   Huvos, A G ^a   Betcher, D L ^a   Baum, E S ^a   Kisker, C T ^a   Miser, J S ^a  

^a Hospital of Indiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; METHOTREXATE;

ADOLESCENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CHILD; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OSTEOSARCOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031022801     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.1.76     Document Type: Article

References (17)

1. Dahlin DC, Coventry MB: Osteosarcoma: A study of six hundred cases. J Bone Joint Surg 49-A:101-110, 1967
2. Marcove RC, Mike V, Hajeh JV, et al: Osteosarcoma under the age of twenty-one: A review of one hundred and forty-five operative cases. J Bone Joint Surg 52:411-423, 1970
3. Edmonson JH, Green SJ, Ivins JC, et al: A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2:152-156, 1984
4. Link MP, Goorin AM, Horowitz M, et al: Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Clin Orthop 270:8-14, 1991
5. Eilber F, Giuliano A, Eckardt J, et al: Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol 5:21-26, 1987
6. Jaffe N, Frei E III, Watts H, et al: High-dose methotrexate in osteosarcoma: A 5-year experience. Cancer Treat Rep 62:259-264, 1978
7. Cortes EP, Holland JF, Glidewell O: Amputation and Adriamycin in primary osteosarcoma. N Engl J Med 291:998-1000, 1974
8. Krailo M, Ertel I, Makley J, et al: A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood non-metastatic osteosarcoma: A report from the Childrens Cancer Study Group. Med Pediatr Oncol 15:69-77, 1987
9. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma - The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2177, 1979
10. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteosarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative therapy. Cancer 49:1221-1230, 1982
11. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
12. Hirji KF, Mehta CR, Patel NR: Computing distributions for exact logistic regression. J Am Stat Assoc 82:1110-1117, 1988
13. Breslow NE, Day NE: Statistical Methods in Cancer Research. Vol 1: The Analysis of Case Control Studies. Lyon, France, IARC, 1980, pp 146-154
14. Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992
15. Winkler K, Beron G, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329-337, 1988
16. Saeter G, Alvegard TA, Elomaa I, et al: Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study. J Clin Oncol 9:1766-1775, 1991
17. Goorin A, Baker A, Gieser P, et al: No evidence for improved event free survival (EFS) with presurgical chemotherapy (PRE) for non-metastatic extremity osteogenic sarcoma (OGS): Preliminary results of randomized Pediatric Oncology Group (POG) trial 8651. Proc Am Soc Clin Oncol 14:444, 1995 (abstr)